Align Technology (ALGN)

• Market cap: $9.57B
• 1 day: 2.01%
• 5 days: -2.57%
• 1 month: -8.9%
• 3 months: -26.65%
• 6 months: -19.75%
• Year to date: -36.67%
• 1 year: -47.81%
• 5 years: -58.86%
• 10 years: 129.95%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Employees: 21,485

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

27% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 88

22% more capital invested

Capital invested by funds: $10.4B [Q1] → $12.7B (+$2.27B) [Q2]

3.36% more ownership

Funds ownership: 88.87% [Q1] → 92.23% (+3.36%) [Q2]

2% more funds holding

Funds holding: 678 [Q1] → 690 (+12) [Q2]

2% more repeat investments, than reductions

Existing positions increased: 245 | Existing positions reduced: 241

0% more funds holding in top 10

Funds holding in top 10: 6 [Q1] → 6 (+0) [Q2]

38% less call options, than puts

Call options by funds: $168M | Put options by funds: $271M

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $154
• Avg. target: $193
• High target: $220

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Stifel Jonathan Block	$200	Buy Maintained	31 Jul 2025
Wells Fargo Vik Chopra	$199	Overweight Maintained	31 Jul 2025
Piper Sandler Jason Bednar	$190	Overweight Maintained	31 Jul 2025
Morgan Stanley Erin Wright	$154	Equal-Weight Downgraded	31 Jul 2025
Evercore ISI Group	$220	Outperform Maintained	9 Jul 2025